Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategies for Enhancing Mucosal Immunity to Influenza Vaccine

NCT01385215 is registered in ClinicalTrials.gov with John Sundy as lead sponsor.

NCT NCT01385215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01385215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategies for Enhancing Mucosal Immunity to Influenza Vaccine
Lead sponsor
John Sundy
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2011
Completion date
June 30, 2011
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucosal immunity